Alivus Life Sciences Limited - Laporan Laba Rugi (TTM)

Alivus Life Sciences Limited
IN ˙ BSE
₹ 1,088.85 ↓ -8.75 (-0.80%)
2025-05-02
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Alivus Life Sciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 18,852 20,131 20,540 20,763 21,232 20,882 20,357 20,540 21,612 22,498 23,359 23,679 22,832 22,934 22,049 22,739 23,869 24,001
Change (%) 6.79 2.03 1.08 2.26 -1.65 -2.51 0.90 5.22 4.10 3.83 1.37 -3.58 0.45 -3.86 3.13 4.97 0.55
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 9,342 10,182 9,954 10,090 10,677 10,124 10,060 10,136 10,468 10,332 10,991 10,765 10,399 10,418 10,318 10,749 11,308 10,634
Change (%) 8.98 -2.24 1.36 5.82 -5.18 -0.64 0.76 3.28 -1.30 6.37 -2.06 -3.39 0.18 -0.96 4.18 5.20 -5.95
% of Revenue 49.56 50.58 48.46 48.59 50.29 48.48 49.42 49.35 48.44 45.93 47.05 45.46 45.55 45.42 46.79 47.27 47.37 44.31
Gross Operating Profit 9,509 9,949 10,586 10,673 10,555 10,758 10,298 10,403 11,144 12,166 12,368 12,915 12,433 12,516 11,731 11,991 12,561 13,367
Change (%) 4.63 6.40 0.82 -1.11 1.92 -4.28 1.03 7.12 9.17 1.66 4.42 -3.73 0.67 -6.27 2.21 4.76 6.41
% of Revenue 50.44 49.42 51.54 51.41 49.71 51.52 50.58 50.65 51.56 54.07 52.95 54.54 54.45 54.58 53.21 52.73 52.63 55.69
SG&A 1,553 1,608 1,669 1,733 1,744 1,722 1,768 1,812 1,896 1,879 2,166 2,391 2,701 2,669 2,745 2,692 2,705 2,564
Change (%) 3.49 3.78 3.89 0.63 -1.26 2.62 2.49 4.66 -0.93 15.32 10.39 12.94 -1.19 2.87 -1.95 0.51 -5.22
% of Revenue 8.24 7.99 8.12 8.35 8.22 8.25 8.68 8.82 8.77 8.35 9.27 10.10 11.83 11.64 12.45 11.84 11.33 10.68
R&D
Change (%)
% of Revenue
OpEx 13,234 14,294 14,329 14,653 15,443 15,246 14,954 15,153 15,605 16,059 16,712 16,786 16,611 17,080 16,529 17,062 17,631 17,680
Change (%) 8.00 0.24 2.26 5.39 -1.27 -1.92 1.33 2.98 2.91 4.06 0.44 -1.04 2.83 -3.23 3.22 3.34 0.28
% of Revenue 70.20 71.00 69.76 70.57 72.73 73.01 73.46 73.77 72.20 71.38 71.55 70.89 72.75 74.48 74.97 75.03 73.87 73.66
Operating Income 5,617 5,837 6,212 6,110 5,789 5,635 5,403 5,387 6,008 6,439 6,647 6,894 6,221 5,853 5,520 5,678 6,238 6,321
Change (%) 3.91 6.42 -1.63 -5.25 -2.66 -4.12 -0.30 11.52 7.17 3.23 3.71 -9.75 -5.91 -5.70 2.86 9.87 1.34
% of Revenue 29.80 29.00 30.24 29.43 27.27 26.99 26.54 26.23 27.80 28.62 28.45 29.11 27.25 25.52 25.03 24.97 26.13 26.34
Interest Expense -875 -853 -706 -490 -280 -75 -5 -6 -5 -8 -11 -13 -15 -15 -14 -15 -24 -33
Change (%) -2.59 -17.21 -30.58 -42.95 -73.01 -93.98 21.81 -1.08 47.71 32.92 21.14 18.83 -2.78 -3.73 4.91 59.03 37.20
% of Revenue -4.64 -4.24 -3.44 -2.36 -1.32 -0.36 -0.02 -0.03 -0.03 -0.04 -0.05 -0.05 -0.07 -0.07 -0.07 -0.07 -0.10 -0.14
Net Income 3,516 3,714 4,142 4,245 4,187 4,265 4,182 4,195 4,670 4,937 5,055 5,193 4,709 4,469 4,235 4,417 4,856 4,957
Change (%) 5.65 11.50 2.50 -1.36 1.87 -1.95 0.31 11.31 5.72 2.40 2.72 -9.32 -5.09 -5.24 4.30 9.95 2.07
% of Revenue 18.65 18.45 20.16 20.45 19.72 20.43 20.54 20.42 21.61 21.94 21.64 21.93 20.62 19.49 19.21 19.42 20.35 20.65

Source: Capital IQ

Other Listings
IN:ALIVUS
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista